Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Novelion Therapeutics Inc (NASDAQ:NVLN)

During the Trading Day
7.50 +0.01 / +0.13%
As of 4:00pm ET
Day’s Change
During After-Hours   Switch to standard view »
7.50 0.00 / 0.00%
 
Volume: 360.00
SECTOR
Health Technology
INDUSTRY
Biotechnology
MARKET CAP
$139.7M

Company Description

Novelion Therapeutics, Inc. develops and markets ocular products. It is engaged in developing new standards of care for individuals living with rare diseases. The company is headquartered in Vancouver, Canada.

Contact Information

Novelion Therapeutics, Inc.
887 Great Northern Way
Vancouver British Columbia V5T 4T5
P:(877) 764-3131
Investor Relations:

Employees

Shareholders

Mutual fund holders9.71%
Other institutional71.38%
Individual stakeholders13.62%

Top Executives

Mary J. SzelaChief Executive Officer & Director
Gregory D. PerryChief Financial & Administrative Officer
Roger W. LouisChief Compliance Officer
Remi A. MenesGlobal Chief Commercial Officer
Linda BuonoSenior Vice President-Human Resources